The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.
Am J Hematol
; 93(11): E355-E357, 2018 11.
Article
in En
| MEDLINE
| ID: mdl-30074268
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Leukemia, Erythroblastic, Acute
Type of study:
Guideline
/
Observational_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Am J Hematol
Year:
2018
Type:
Article